Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP491879.RACQcOuN6wt2S-zx2zbbYmewLoL0CHO9EcSR_g3fqQDtk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP491879.RACQcOuN6wt2S-zx2zbbYmewLoL0CHO9EcSR_g3fqQDtk130_assertion type Assertion NP491879.RACQcOuN6wt2S-zx2zbbYmewLoL0CHO9EcSR_g3fqQDtk130_head.
- NP491879.RACQcOuN6wt2S-zx2zbbYmewLoL0CHO9EcSR_g3fqQDtk130_assertion description "[We report that aged (>6 months) transgenic (tg) mice expressing CCL2 under the control of the human glial fibrillary acidic protein promoter (huGFAP-CCL2hi tg+ mice) manifested encephalopathy with mild perivascular leukocyte infiltration, impaired blood brain barrier function, and increased CD45-immunoreactive microglia, which had morphologic features of activation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP491879.RACQcOuN6wt2S-zx2zbbYmewLoL0CHO9EcSR_g3fqQDtk130_provenance.
- NP491879.RACQcOuN6wt2S-zx2zbbYmewLoL0CHO9EcSR_g3fqQDtk130_assertion evidence source_evidence_literature NP491879.RACQcOuN6wt2S-zx2zbbYmewLoL0CHO9EcSR_g3fqQDtk130_provenance.
- NP491879.RACQcOuN6wt2S-zx2zbbYmewLoL0CHO9EcSR_g3fqQDtk130_assertion SIO_000772 15857890 NP491879.RACQcOuN6wt2S-zx2zbbYmewLoL0CHO9EcSR_g3fqQDtk130_provenance.
- NP491879.RACQcOuN6wt2S-zx2zbbYmewLoL0CHO9EcSR_g3fqQDtk130_assertion wasDerivedFrom befree-2016 NP491879.RACQcOuN6wt2S-zx2zbbYmewLoL0CHO9EcSR_g3fqQDtk130_provenance.
- NP491879.RACQcOuN6wt2S-zx2zbbYmewLoL0CHO9EcSR_g3fqQDtk130_assertion wasGeneratedBy ECO_0000203 NP491879.RACQcOuN6wt2S-zx2zbbYmewLoL0CHO9EcSR_g3fqQDtk130_provenance.